Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Published Phase 3 weight-loss results for retatrutide exceed those reported for tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints [1][2][9]
J Hepatol 71(4):793801
O-16 never too late: delayed diagnosis of Prader-Willi syndrome
Direct Clinical Guidance: These visits provide an ongoing opportunity to sit down face-to-face with your medical team
About $297 per month flat for compounded semaglutide and about $449 for injectable compounded tirzepatide, with prepay plans lowering the monthly figure
Nausea, constipation, diarrhea, bloating, and reduced appetite are reported with both
US$ 23.57
:max_bytes(150000):strip_icc()/VWH-GettyImages-1469751146-5eff6dd0b38449ff9dca9313c7c393d5.jpg)
US$ 27.16
US$ 27.92
US$ 25.66
US$ 28.32
